• Progyny will present research on its employer-sponsored Menopause and Midlife program October 22, 2026, at The Menopause Society annual meeting.
• The study, conducted with Morehouse School of Medicine, evaluated access, engagement and symptom changes among participating women.
• Chief Medical Officer Janet Choi said the research demonstrates potential to broaden access to menopause expertise while meaningfully improving symptoms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Progyny Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610150934PRIMZONEFULLFEED9846566) on October 15, 2026, and is solely responsible for the information contained therein.